THROMBOSIS UPDATE AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Abstracting and Indexing p.1 • Editorial Board p.1 • Guide for Authors p.3 ISSN: 2666-5727 DESCRIPTION . Thrombosis Update is an International Open Access journal publishing basic, translational and clinical research in vascular biology, thrombosis and hemostasis. Thrombosis Update is a companion Journal to Thrombosis Research and will also publish novel cellular and molecular studies and new developments in the diagnosis, therapy, prognosis of thrombotic and vascular diseases. The journal publishes high quality original research, review articles, case reports and brief communications. ABSTRACTING AND INDEXING . Directory of Open Access Journals (DOAJ) EDITORIAL BOARD . Co Editors-in-Chief Lucy A. Norris, Trinity College Dublin, Department of Obstetrics and Gynaecology, Trinity Centre for Health Sciences, St. James Hospital, Dublin, Ireland Haemostasis and thrombosis, Women's health, Coagulation, Thrombosis &, Cancer Emmanouil S. Papadakis, Papageorgiou Hospital, Hemostasis Unit-Hematology Department, Thessaloniki, Greece Editorial Advisory Board Cihan Ay, Medical University of Vienna Department of Internal Medicine, Vienna, Austria Stefano Barco, University Hospital Zurich Department of Angiology, Zurich, Switzerland Venous thromboembolism, Clinical studies, Angiology, Anticoagulants Laurent Bertoletti, Service de Médecine Vasculaire et Thérapeutique, Hôpital Nord, CHU de St-Etienne; INSERM, SAINBIOSE, U1059, Dysfonction Vasculaire et Hémostase, Université Jean-Monnet, Saint-Etienne, France; INSERM, CIC1408, F- 42055 Saint-Etienne, France., St Etienne France Vascular medicine, Particularly pulmonary vascular diseases, As pulmonary embolism and pulmonary hypertensions Sylvie Bouvier, University Hospital Group Caremeau, Nimes, France Hyper-coagulability, fDNA Sergio Coccheri, MD, Ph.D, University of Bologna, Bologna, Italy Hematology, Vascular medicine, Cardiology, Atherosclerosis Nathan T. Connell, Brigham and Women's Hospital Division of Hematology, Boston, Massachusetts, United States of America AUTHOR INFORMATION PACK 1 Oct 2021 www.elsevier.com/locate/tru 1 Bleeding disorders, Coagulation disorders, Hematology, Hemolytic anemia, Hemophilia, Iron overload, Red cell disorders, Thrombocytopenia, Thrombophilia, Thrombotic disorders, Transfusion medicine Martin Ellis, Meir Medical Center, Kfar Sava, Israel VTE's, Anti coagulation Colin Evans, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America Vascular biology, Cancer biology, Thrombosis, Cancer research Elisavet Grouzi, Agios Savvas General Cancer and Oncology Hospital of Athens, Athens, Greece Platelets, Hemostasis, Thrombosis, Immunotherapy, Blood Coagulation, Leukemia Nina Iversen, Oslo University Hospital, Oslo, Norway Cancer Cells, Cancer Research, Gene Expression, Apoptosis, Molecular Biology David Jiménez, MD, Ramon y Cajal University Hospital, Madrid, Spain Pulmonary embolism Krasimir Kolev, Semmelweis University, Department of Medical Biochemistry, Budapest, Hungary Fibrinolysis, Thrombosis, Platelets, Coagulation, Blood Coagulation, Hemostasis Wolfgang Miesbach, Hospital of the Goethe University Frankfurt Institute of Medical Virology, Frankfurt am Main, Germany Coagulation, Haemophilia, Gene Therapy Fionnuala Ni Ainle, Mater Misericordiae University Hospital, Dublin, Ireland Thrombosis, Haemostasis and Maternal Haematology Simon Noble, MBBS, MD, FRCP, Cardiff University School of Medicine, Cardiff, United Kingdom Palliative Medicine, Cancer associated thrombosis Benght Zoller, Lund University Department of Clinical Sciences Malmo, Malmö, Sweden Venous thromboembolism, Venous thrombosis, Pulmonary embolism, Thrombophilia, Genetics, Epidemiology Social Media Editor Shane Comer, University College Dublin, Dublin, Ireland Editorial Board, Early Career Researchers Nirav Dhanesha, The University of Iowa Healthcare, Iowa City, Iowa, United States of America Hematology, Oncology and Blood and Marrow Transplantation Renee Eslick, South Western Sydney Local Health District, Sydney, Australia Cancer Therapy Eleni Gavriilaki, General Hospital of Thessaloniki G Papanikolaou, Thessaloniki, Greece Hematology, Vascular Medicine, Hypertension, Thrombotic microangiopathy, Platelets Andaleb Kholmukhamedov, Versiti Blood Research Institute Milwaukee, Milwaukee, Wisconsin, United States of America Platelet Physiology and Pathophysiology Joshua Muia, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma, United States of America DNA Extraction, Cloning, Electropheresis Frits Mulder, Academic Medical Center, Department of Vascular Medicine, Amsterdam, Netherlands Vascular Disease, VTE and Cancer Jamie O'Sullivan, Royal College of Surgeons in Ireland, Dublin, Ireland Coagulation and Cancer AUTHOR INFORMATION PACK 1 Oct 2021 www.elsevier.com/locate/tru 2 GUIDE FOR AUTHORS . Your Paper Your Way We now differentiate between the requirements for new and revised submissions. You may choose to submit your manuscript as a single Word or PDF file to be used in the refereeing process. Only when your paper is at the revision stage, will you be requested to put your paper in to a 'correct format' for acceptance and provide the items required for the publication of your article. To find out more, please visit the Preparation section below. INTRODUCTION Thrombosis Update is an International Open Access journal publishing basic, translational and clinical research in vascular biology, thrombosis and hemostasis. Thrombosis Update is a companion Journal to Thrombosis Research and will also publish novel cellular and molecular studies and new developments in the diagnosis, therapy, prognosis of thrombotic and vascular diseases. The journal publishes high quality original research, review articles, case reports and brief communications. Types of Article The following manuscripts will be considered for publication. Full Length Articles are reports of original work. (5-6,000 words) Review Articles constitute a literature review of a particular area and can be clinical or concentrate on a basic science topic. (5-6,000 words) Case Reports concerning interesting and topical cases or treatments of interest to researchers in our field. (1,500 words, 10 references, up to 4 figures or 4 tables) Submission checklist You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details. Ensure that the following items are present: One author has been designated as the corresponding author with contact details: • E-mail address • Full postal address All necessary files have been uploaded: Manuscript: • Include keywords • All figures (include relevant captions) • All tables (including titles, description, footnotes) • Ensure all figure and table citations in the text match the files provided • Indicate clearly if color should be used for any figures in print Graphical Abstracts / Highlights files (where applicable) Supplemental files (where applicable) Further considerations • Manuscript has been 'spell checked' and 'grammar checked' • All references mentioned in the Reference List are cited in the text, and vice versa • Permission has been obtained for use of copyrighted material from other sources (including the Internet) • A competing interests statement is provided, even if the authors have no competing interests to declare • Journal policies detailed in this guide have been reviewed • Referee suggestions and contact details provided, based on journal requirements For further information, visit our Support Center. For any submission questions, please contact the Editorial Office at [email protected]. BEFORE YOU BEGIN Ethics in publishing Please see our information on Ethics in publishing. AUTHOR INFORMATION PACK 1 Oct 2021 www.elsevier.com/locate/tru 3 Studies in humans and animals If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed. All animal experiments should comply with the ARRIVE guidelines and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments, or the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978) and the authors should clearly indicate in the manuscript that such guidelines have been followed. The sex of animals must be indicated, and where appropriate, the influence (or association) of sex on the results of the study. Informed consent and patient details Studies on patients or volunteers require ethics committee approval and informed consent, which should be documented in the paper. Appropriate consents, permissions and releases must be obtained where